Download PDF
CC BY-NC-ND 4.0 · Rofo 2023; 195(02): 150-152
DOI: 10.1055/a-1949-7549
The Interesting Case

Case report: Acute transverse myelitis in COVID-19 infection with delayed onset of pulmonary manifestation

Fallbericht: Akute Myelitis transversa in COVID-19-Infektion mit verzögertem Beginn der pulmonalen Manifestation
Emina Talakic 
1   Division of General Radiology, Department of Radiology, Medical University of Graz (MUG), Graz, Austria
,
Ann Kathrin Kaufmann-Bühler 
1   Division of General Radiology, Department of Radiology, Medical University of Graz (MUG), Graz, Austria
,
Elmar Janek 
1   Division of General Radiology, Department of Radiology, Medical University of Graz (MUG), Graz, Austria
,
Peter Mrak
3   Department of Internal Medicine II, LKH Weststeiermark, Voitsberg, Austria
,
Michael Fuchsjäger 
1   Division of General Radiology, Department of Radiology, Medical University of Graz (MUG), Graz, Austria
,
Helmut Schöllnast
1   Division of General Radiology, Department of Radiology, Medical University of Graz (MUG), Graz, Austria
2   Institute of Radiology, LKH Graz II, Graz, Austria
› Author AffiliationsThe author received no financial support for the research, authorship, and/or publication of this article.
› Further Information
Also available at
   Permissions and Reprints

Introduction

COVID-19 disease, caused by the novel beta-coronavirus SARS-CoV-2, has become a global pandemic, with more than 220 million confirmed cases reported to the World Health Organization (WHO) by September 2021 (WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int. Accessed 6 September 2021). The virus causes mild to moderate respiratory illness and most patients recover without requiring special treatment. However, some will become seriously ill with atypical pneumonia and acute respiratory distress syndrome (ARDS), with some cases being fatal. SARS-CoV-2 enters human cells by binding to angiotensin-converting enzyme-2 (ACE2) receptors. These receptors are expressed not only in the lung epithelium, but also in numerous other organs and tissues, such as vascular endothelial cells, heart, brain, kidney, liver, and intestine, which explains the broad spectrum of extrapulmonary symptoms reported for COVID-19-disease (Machhi J. J Neuroimmune Pharmacol. 2020; 15(3): 359–386)



Publication History

Article published online:
17 October 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany